Background: The EAWE (Examination of Anomalous World Experience) is a newly developed, semi-structured interview that aims to capture anomalies of subjectivity, common in schizophrenia spectrum disorders, that pertain to experiences of the lived world, including space, time, people, language, atmosphere, and certain existential attitudes. By contrast, previous empirical studies of subjective experience in schizophrenia have focused largely on disturbances in self-experience. Aim: To assess the reliability of the EAWE, including internal consistency and interrater reliability. Sampling and Methods: In the course of developing the EAWE, two distinct studies were conducted, one in the United States and the other in Slovenia. Thirteen patients diagnosed with schizophrenia spectrum or mood disorders were recruited for the US study. Fifteen such patients were recruited for the Slovenian study. Two live interviewers conducted the EAWE in the US. The Slovenian interviews were completed by one live interviewer with a second rater reviewing audiorecordings of the interview. Internal consistency and interrater reliability were calculated independently for each study, utilizing Cronbach's α, Spearman's ρ, and Cohen's κ. Results: Each study yielded high internal consistency (Cronbach's α >0.82) and high interrater reliability for total EAWE scores (ρ > 0.83; average κ values were at least 0.78 for each study, with EAWE domain-specific κ not lower than 0.73). Conclusion: The EAWE, containing world-oriented inquiries into anomalies in subjective experience, has adequate reliability for use in a clinical or research setting.

Keywords:
Reliability, Interrater reliability, Examination of Anomalous World Experience, Phenomenology, Phenomenological psychopathology, Schizophrenia
1.
Sass L, Pienkos E, Skodlar B, Stanghellini G, Fuchs T, Parnas J, Jones, N: EAWE: Examination of Anomalous World Experience. Psychopathology 2017, DOI: 10.1159/000454928.
2.
Raballo A, Sæbye D, Parnas J: Looking at the schizophrenia spectrum through the prism of self-disorders: an empirical study. Schizophr Bull 2011;37:344-351.
3.
Parnas J, Handest P, Jansson L, Sæbye D: Anomalous subjective experiences among first-admitted schizophrenia spectrum patients: empirical investigation. Psychopathology 2005;36:259-267.
4.
Parnas J, Handest P, Sæbye D, Jansson L: Anomalies of subjective experience in schizophrenia and psychotic bipolar illness. Acta Psychiatr Scand 2003;108:126-133.
5.
Davidsen K: Anomalous self-experience in adolescents at risk of psychosis. Clinical and conceptual elucidation. Psychopathology 2009:42;361-369.
6.
Parnas J, Møller P, Kircher T, Jørgen T, Jansson L, Handest P, Zahavi D: Examination of anomalous self-experience. Psychopathology 2005;38:236-258.
7.
Sass L, Pienkos E, Fuchs T: Other worlds: introduction to special issue on the EAWE: Examination of anomalous world experience. Psychopathology, in preparation.
8.
Conerty J: The examination of Anomalous World-Experience in Schizophrenia and Other Disorders: An Exploratory Investigation; dissertation, Rutgers University, Piscataway, 2013.
9.
Møller P, Haug E, Raballo A, Parnas J, Melle I: Examination of anomalous self-experience in first-episode psychosis: interrater reliability. Psychopathology 2011;44:386-390.
10.
Landis J: The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
11.
Vollmer-Larsen A, Handest P, Parnas J: Reliability of measuring anomalous experience: the Bonn Scale for the Assessment of Basic Symptoms. Psychopathology 2007;40:345-348.
12.
Sass L, Pienkos E, Nelson B, Medford N: Anomalous self-experience in depersonalization and schizophrenia: a comparative investigation. Conscious Cogn 2013;22:430-441.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.